Bliss GVS Pharma Limited — Others, 16-01-2025: Change in Management

Mr. Dinesh S. Shetty's tenure as General Manager at Bliss GVS Pharma has officially concluded as of December 31, 2024, per the company's superannuation policy. The company acknowledges a delay in communicating this update, attributing it to an unintentional oversight, and has committed to enhancing internal processes for future compliance.

This leadership change could prompt a reassessment of company strategy and operations, though the firm’s commitment to regulatory adherence signals a positive outlook. Investors may view this transition as a neutral impact unless new leadership direction is clarified.